Amgen (AMGN) Tops Q2 EPS by 69c, Beats on Revenue; Offers FY26 Guidance
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $385.65 +1.55%
Revenue Growth %: +5.1%
Financial Fact:
Operating income: 2.53B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +5.1%
Financial Fact:
Operating income: 2.53B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q2 EPS of $6.29, $0.69 better than the analyst estimate of $5.60. Revenue for the quarter came in at $10.1 billion versus the consensus estimate of $9.43 billion.
GUIDANCE:
Amgen sees FY2026 EPS of $22.30-$23.50, versus the consensus of $22.35. Amgen sees FY2026 revenue of $38.2-39.4 billion, versus the consensus of $37.7 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Faraday Future unveils nine robot models, prices start at $9,990
- Axion Minerals plans flow-through private placement of up to $440K
- Lockheed Martin wins $871 million F-35 contract modification
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
